YABAO PHARM.CORP released its performance for the first three quarters, with a net profit attributable to the parent company of 215 million yuan, a year-on-year decrease of 8.44%
According to the Zhitong Finance APP, YABAO PHARM.CORP disclosed its third-quarter report for 2025. The company achieved revenue of 1.709 billion yuan in the first three quarters, a year-on-year decrease of 19.46%; the net profit attributable to the parent company was 215 million yuan, a year-on-year decrease of 8.44%; the net profit excluding non-recurring gains and losses was 197 million yuan, a year-on-year decrease of 9.03%; and the basic earnings per share were 0.3066 yuan
According to the Zhitong Finance APP, YABAO PHARM.CORP (600351.SH) disclosed its third-quarter report for 2025. The company achieved a revenue of 1.709 billion yuan in the first three quarters, a year-on-year decrease of 19.46%; the net profit attributable to the parent company was 215 million yuan, a year-on-year decrease of 8.44%; the net profit excluding non-recurring gains and losses was 197 million yuan, a year-on-year decrease of 9.03%; the basic earnings per share were 0.3066 yuan
